Summary of Significant Accounting Policies - Schedule of Concentration (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Janssen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage		30.00%	30.00%
Janssen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	15.00%	30.00%	33.00%
Biogen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	19.00%	11.00%
Biogen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	13.00%	10.00%
Cardinal Health | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	24.00%	17.00%	16.00%
Cardinal Health | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	24.00%	20.00%	21.00%
AmerisourceBergen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	18.00%	13.00%	11.00%
AmerisourceBergen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	14.00%	11.00%	10.00%
McKesson | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	12.00%	11.00%
McKesson | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	16.00%	13.00%	14.00%